DOUG PEELER: Open Payments
NPI 1114077252 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 15 payments from 8 companies in 2025. Trend: 2023 $1,311 · 2024 $1,767 · 2025 $1,703
Food & beverage: $1,703
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $793 |
| AstraZeneca Pharmaceuticals LP | 2 | $247 |
| KYOWA KIRIN, INC. | 1 | $130 |
| Corcept Therapeutics | 1 | $126 |
| Exeltis, USA Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $117 |
| Astellas Pharma US Inc | 1 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $51 |
Products named: KRYSTEXXA, CRYSVITA, AIRSUPRA, Korlym, BREZTRI, Ozempic, Veozah, REPATHA.
Industry payments across FL — which companies pay providers there.
